ClinicalTrials.gov
public full text
Public Domain
Fractional Carbon Dioxide Laser,Topical Corticosteroid and Narrow Band Ultraviolet B in Treatment of Stable Vitiligo
Vitiligo is an acquired disease with a variable course. It is characterized clinically by well-defined depigmented macules or patches thought to occur secondary to melanocyte dysfunction and loss. it is the most common depigmentation disorder, affecting approximately 0.5 to 2.0 percent of the population and has no predilection for gender or race .
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Quality of life impairment in vitiligo: A comprehensive review of psychosocial and clinical determinants.#171896
- Topical Methotrexate with Fractional CO2 Laser in Treatment of Non Segmental Vitiligo#872065
- Optimal Treatment Frequency of 308-Nm Excimer Laser for Vitiligo on the Face and Neck#1047071
- Comparison of Surgical Methods on Resistant Sites in Stable Vitiligo Patients#184875
- CGA Sicilia - Ricorsi pervenuti per tipologia — CGA Sicilia - Ricorsi pervenuti per tipologia - 2025#144437
Record · ID 1103669
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive